Dr. Lal PathLabs Limited (“Dr. Lal PathLabs”), one of India’s most trusted diagnostics brands, today announced the launch of Sovaaka, its new-age Diagnostic Experience Centre in Gurugram. The launch event was graced by the Hon’ble Chief Minister of Haryana, Shri Nayab Singh Saini. Built on the philosophy
In a pioneering move set to transform cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to adopt a deep learning-based AI module to detect lymph node metastasis, including micrometastasis, in cancer cases. This cutting-edge technology, validated in
Dr. Lal PathLabs Limited (“DLPL”), one of India’s most trusted diagnostic chains, has expanded its genomics capabilities by adding Illumina’s NovaSeq™ X Series to its dedicated genomics division, Genevolve. With the integration of Illumina’s latest technology, DLPL can now deliver faster and more accurate genomic
Dr. Lal PathLabs Limited (“DLPL” / “Dr. Lal PathLabs”), a leader in diagnostic healthcare, has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry – a breakthrough test for accurately identifying different types of Amyloid proteins. With this launch, DLPL becomes the first diagnostic
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
